• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创伤弧菌中弧菌素和胞外蛋白酶在利用转铁蛋白和乳铁蛋白结合铁中的作用。

Involvement of vulnibactin and exocellular protease in utilization of transferrin- and lactoferrin-bound iron by Vibrio vulnificus.

作者信息

Okujo N, Akiyama T, Miyoshi S, Shinoda S, Yamamoto S

机构信息

Faculty of Pharmaceutical Sciences, Okayama University, Japan.

出版信息

Microbiol Immunol. 1996;40(8):595-8. doi: 10.1111/j.1348-0421.1996.tb01114.x.

DOI:10.1111/j.1348-0421.1996.tb01114.x
PMID:8887355
Abstract

In vitro growth experiments were conducted to evaluate the ability of vulnibactin, a siderophore produced by Vibrio vulnificus, to sequester transferrin- or lactoferrin bound iron for growth. Comparative studies with the strain producing vulnibactin and its exocellular protease-deficient mutant revealed the involvement of the protease in addition to vulnibactin in effective utilization of iron ion (Fe3+) bound to transferrin and lactoferrin. It appears that the protease causes cleavage of these proteins, thereby making bound iron more accessible to vulnibactin.

摘要

进行了体外生长实验,以评估创伤弧菌产生的一种铁载体——创伤弧菌素,螯合与转铁蛋白或乳铁蛋白结合的铁以供生长的能力。对产生创伤弧菌素的菌株及其细胞外蛋白酶缺陷型突变体进行的比较研究表明,除创伤弧菌素外,蛋白酶也参与了对与转铁蛋白和乳铁蛋白结合的铁离子(Fe3+)的有效利用。看来蛋白酶会导致这些蛋白质的裂解,从而使结合的铁更容易被创伤弧菌素获取。

相似文献

1
Involvement of vulnibactin and exocellular protease in utilization of transferrin- and lactoferrin-bound iron by Vibrio vulnificus.创伤弧菌中弧菌素和胞外蛋白酶在利用转铁蛋白和乳铁蛋白结合铁中的作用。
Microbiol Immunol. 1996;40(8):595-8. doi: 10.1111/j.1348-0421.1996.tb01114.x.
2
IutB participates in the ferric-vulnibactin utilization system in Vibrio vulnificus M2799.IutB参与创伤弧菌M2799中的铁-创伤弧菌素利用系统。
Biometals. 2017 Apr;30(2):203-216. doi: 10.1007/s10534-017-9994-0. Epub 2017 Feb 1.
3
Effect of the crp mutation on the utilization of transferrin-bound iron by Vibrio vulnificus.crp突变对创伤弧菌利用转铁蛋白结合铁的影响。
FEMS Microbiol Lett. 2006 Apr;257(2):285-92. doi: 10.1111/j.1574-6968.2006.00183.x.
4
Role of periplasmic binding proteins, FatB and VatD, in the vulnibactin utilization system of Vibrio vulnificus M2799.类脂载体结合蛋白 FatB 和 VatD 在创伤弧菌 M2799 利用 vulnibactin 系统中的作用。
Microb Pathog. 2013 Dec;65:73-81. doi: 10.1016/j.micpath.2013.10.002. Epub 2013 Oct 14.
5
Cloning and characterization of vuuA, a gene encoding the Vibrio vulnificus ferric vulnibactin receptor.创伤弧菌铁载体受体基因vuuA的克隆与特性分析
Infect Immun. 2000 Feb;68(2):526-34. doi: 10.1128/IAI.68.2.526-534.2000.
6
VuuB and IutB reduce ferric-vulnibactin in Vibrio vulnificus M2799.VuuB 和 IutB 降低创伤弧菌 M2799 中的铁载体 Vulnibactin。
Biometals. 2020 Oct;33(4-5):187-200. doi: 10.1007/s10534-020-00241-5. Epub 2020 Jul 17.
7
Vibrio vulnificus vulnibactin, but not metalloprotease VvpE, is essentially required for iron-uptake from human holotransferrin.创伤弧菌的铁载体蛋白(vulnibactin)而非金属蛋白酶VvpE,对于从人全转铁蛋白摄取铁至关重要。
Biol Pharm Bull. 2006 May;29(5):911-8. doi: 10.1248/bpb.29.911.
8
Ferrophilic characteristics of Vibrio vulnificus and potential usefulness of iron chelation therapy.创伤弧菌的嗜铁特性及铁螯合疗法的潜在用途。
J Infect Dis. 2007 Jan 1;195(1):90-8. doi: 10.1086/509822. Epub 2006 Nov 22.
9
[New Drug Discovery Targeting Iron in Bacterial Infectious Diseases].[针对细菌感染性疾病中铁元素的新药研发靶点]
Yakugaku Zasshi. 2024;144(6):633-641. doi: 10.1248/yakushi.23-00197-2.
10
The RND protein is involved in the vulnibactin export system in Vibrio vulnificus M2799.RND蛋白参与创伤弧菌M2799中的vulnibactin输出系统。
Microb Pathog. 2014 Oct;75:59-67. doi: 10.1016/j.micpath.2014.09.001. Epub 2014 Sep 6.

引用本文的文献

1
Proteomics and H NMR-based metabolomics analysis of pathogenic Vibrio vulnificus aquacultures isolated from sewage drains.从污水渠中分离的致病性创伤弧菌养殖物的蛋白质组学和基于 1H NMR 的代谢组学分析。
Environ Sci Pollut Res Int. 2017 Oct;24(30):23704-23713. doi: 10.1007/s11356-017-0007-1. Epub 2017 Sep 1.
2
Myroilysin Is a New Bacterial Member of the M12A Family of Metzincin Metallopeptidases and Is Activated by a Cysteine Switch Mechanism.肌溶素是金属锌肽酶M12A家族的一种新型细菌成员,通过半胱氨酸开关机制被激活。
J Biol Chem. 2017 Mar 31;292(13):5195-5206. doi: 10.1074/jbc.M116.758110. Epub 2017 Feb 9.
3
Spoxazomicin D and Oxachelin C, Potent Neuroprotective Carboxamides from the Appalachian Coal Fire-Associated Isolate Streptomyces sp. RM-14-6.
斯波沙唑霉素D和奥沙西林C,来自阿巴拉契亚煤火相关菌株链霉菌RM-14-6的强效神经保护羧酰胺。
J Nat Prod. 2017 Jan 27;80(1):2-11. doi: 10.1021/acs.jnatprod.6b00948. Epub 2016 Dec 28.
4
Iron- and Quorum-sensing Signals Converge on Small Quorum-regulatory RNAs for Coordinated Regulation of Virulence Factors in Vibrio vulnificus.铁信号与群体感应信号汇聚于小群体调控RNA,以协同调控创伤弧菌的毒力因子
J Biol Chem. 2016 Jul 1;291(27):14213-14230. doi: 10.1074/jbc.M116.714063. Epub 2016 May 5.
5
Vibrio Iron Transport: Evolutionary Adaptation to Life in Multiple Environments.弧菌铁转运:对多种环境生存的进化适应
Microbiol Mol Biol Rev. 2015 Dec 9;80(1):69-90. doi: 10.1128/MMBR.00046-15. Print 2016 Mar.
6
Genotype is correlated with but does not predict virulence of Vibrio vulnificus biotype 1 in subcutaneously inoculated, iron dextran-treated mice.基因型与创伤弧菌 1 型生物型的毒力相关,但不能预测其在皮下接种、铁葡聚糖处理的小鼠中的毒力。
Infect Immun. 2011 Mar;79(3):1194-207. doi: 10.1128/IAI.01031-10. Epub 2011 Jan 3.
7
USER friendly cloning coupled with chitin-based natural transformation enables rapid mutagenesis of Vibrio vulnificus.用户友好型克隆与基于几丁质的自然转化相结合,可实现创伤弧菌的快速诱变。
Appl Environ Microbiol. 2009 Aug;75(15):4936-49. doi: 10.1128/AEM.02564-08. Epub 2009 Jun 5.
8
Vibriobactin antibodies: a vaccine strategy.耶尔森氏菌素抗体:一种疫苗策略。
J Med Chem. 2009 Jun 25;52(12):3801-13. doi: 10.1021/jm900119q.
9
Vibrio vulnificus: disease and pathogenesis.创伤弧菌:疾病与发病机制
Infect Immun. 2009 May;77(5):1723-33. doi: 10.1128/IAI.01046-08. Epub 2009 Mar 2.
10
Survival of and in situ gene expression by Vibrio vulnificus at varying salinities in estuarine environments.河口环境中不同盐度下创伤弧菌的存活及原位基因表达
Appl Environ Microbiol. 2008 Jan;74(1):182-7. doi: 10.1128/AEM.02436-07. Epub 2007 Nov 9.